Printer Friendly

CELLEX BIOSCIENCES, INC. DEFENDS CLAIM OF TRADEMARK INFRINGEMENT

 MINNEAPOLIS, June 29 /PRNewswire/ -- Cellex Biosciences, Inc. (NASDAQ: CLXX) reported today that a suit has been filed against it in U.S. District Court for the District of Minnesota alleging that Cellex Biosciences, Inc. has violated certain state and federal trademark and tradename provisions by the use of its new name, Cellex Biosciences, Inc., adopted on May 12, 1993, and by the use of its stock symbol, CLXX. The suit is brought by Celox Corporation (NASDAQ Small-Cap Market: CELX) of Hopkins, Minn., which seeks to prohibit Cellex Biosciences from using its name as well as damages in excess of $50,000.
 Cellex Biosciences believes that the claims asserted against it are without merit and intends to vigorously defend this lawsuit.
 Cellex Biosciences, Inc., headquartered in Minneapolis, is dedicated to providing cell processing products and services to meet the needs of human health care and biotechnology markets worldwide.
 -0- 6/29/93
 /CONTACT: Yvonne L. Marschner-Bova, director, investor relations, Cellex Biosciences, Inc., 313-871-7350/
 (CLXX CELX)


CO: Cellex Biosciences, Celox Corporation ST: Minnesota IN: MTC SU:

JG -- DE027 -- 6838 06/29/93 15:46 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 29, 1993
Words:183
Previous Article:MICHAEL McCANHAM TO JOIN WXYZ-TV/CHANNEL 7 AS ASSIGNMENT MANAGER
Next Article:MICHIGAN OTC CHANGES, PROVIDED BY FIRST OF MICHIGAN CORP., TODAY: TUESDAY, JUNE 29, 1993
Topics:


Related Articles
CELLEX BIOSCIENCES, INC. RECEIVES $500,000 GOVERNMENT GRANT FOR FURTHER DEVELOPMENT OF ITS OXYCELL BIOREACTOR
CELLEX BIOSCIENCES, INC. ENTERS INTO DISTRIBUTION AGREEMENT WITH TOSOH CORPORATION OF JAPAN
CELOX CORPORATION FILES TRADEMARK SUIT AGAINST FORMER ENDOTRONICS
CELLEX BIOSCIENCES APPOINTS VICE PRESIDENT, SALES AND MARKETING
CELLEX BIOSCIENCES, INC. TO HOLD ANNUAL MEETING
REGENEREX, INC. APPOINTS PRESIDENT, COO TO LEAD DEVELOPMENT PROGRAM FOR ARTIFICIAL LIVER
CELLEX BIOSCIENCES ANNOUNCES AGREEMENT TO JOIN FORCES WITH LSL GROUP, LTD.
CELLEX BIOSCIENCES SUBSIDIARY LSL BIOLAFITTE USA NAMES HOWARD J. LANGEJANS PRESIDENT AND GENERAL MANAGER
CELLEX BIOSCIENCES ANNOUNCES LSL BIOLAFITTE ORDER FROM GENENCOR INTERNATIONAL INC.
CELLEX BIOSCIENCES Announces Termination of Merger Agreement With UNISYN Technologies, Discussions Continuing

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters